Title: Jin Ding, et al. ψ-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling. Oncotarget. 2015 May 10; 6(13): 11627–11639.
464-74-4
472-26-4
465-11-2
465-19-0
465-21-4
20987-24-0
230615-23-3 | 6,10-Methano-6H-pyrazino[2,3-h][3]benzazepine, 6,7,8,9-tetrahydro-, monohydrochloride | AA00BFJQ | MFCD11042277
350-27-6 | 3-Fluoro-4-methoxyphenacyl bromide | AA00C8OZ | MFCD00466240
51250-91-0 | BIS(P-NITROPHENYL) AZIDOPHOSPHONATE | AA00DED3 | MFCD08274943
63263-88-7 | 1-Benzyl-1h-indole-5-carbaldehyde | AA00EE9P | MFCD09455245
84719-33-5 | Pyridine-2,5-diol | AA00G5C2 | MFCD00234075
1142188-69-9 | 5-Bromo-2-hydroxy-4-methylnicotinonitrile | AA00HCPA | MFCD23381292
1426290-11-0 | 2-Bromo-4-(trifluoromethoxy)phenylacetylene | AA00HWGD | MFCD23166760
37640-57-6 | Melamine Cyanurate | AA00I7C6 | MFCD00137334
887266-94-6 | 1-Benzoyl-3-[4-bromo-2-(trifluoromethyl)phenyl]thiourea | AA00IFAB | MFCD07368704
1932555-95-7 | (2R,4R)-1-(tert-Butoxycarbonyl)-2-methylpiperidine-4-carboxylic acid | AA00IL9O | MFCD29058646
